Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

Bibliography

• Speroff L. A good man. Portland, OR: Arnica Pub, Inc, 2009
   Google Scholar
• Speroff L, Darney P. A clinical guide for contraception, 4th edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 2005
   Google Scholar
• Zeun S, Lu M, Uddin A, Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2009;14:221-32
   PubMed Web of Science ®Google Scholar
• Mosher WD, Martinez GM, Chandra A, Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004;350:1-36
   Google Scholar
• Rosenberg MJ, Burnhill MS, Waugh MS, Compliance and oral contraceptives: a review. Contraception 1995;52:137-41
   PubMed Web of Science ®Google Scholar
• Jensen JT, Speroff L. Health benefits of oral contraceptives. Obstet Gynecol Clin North Am 2000;27:705-21
   PubMed Web of Science ®Google Scholar
• Gallo MF, Nanda K, Grimes DA, Schulz KF. 20 mcg versus > 20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2005;2:CD003989-
   Google Scholar
• Astedt B, Jeppsson S, Liedholm P, Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol. Br J Obstet Gynaecol 1979;86:732-6
   PubMedGoogle Scholar
• World Health Organization Task Force on Oral Contraception. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. Contraception 1980;21:445-59
   PubMed Web of Science ®Google Scholar
• Hirvonen E, Stenman UH, Malkonen M, New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women. Maturitas 1988;10:201-13
   PubMed Web of Science ®Google Scholar
• Csemiczky G, Dieben T, Coeling Bennink HJ, Landgren BM. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days. Contraception 1996 54:333-8
   PubMed Web of Science ®Google Scholar
• Oettel M, Breitbarth H, Elger W, The pharmacological profile of dienogest. Eur J Contracept Reprod Health Care 1999;4(1 Suppl 1):2-13
   Google Scholar
• Endrikat J, Parke S, Trummer D, Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies. Contraception 2008;78:218-25
   PubMed Web of Science ®Google Scholar
• Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999;181:1263-9
   PubMed Web of Science ®Google Scholar
• Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott, Williams & Wilkins, 2004
   Google Scholar
• Sulak P, Scow R, Preece C, Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95:261-6
   PubMed Web of Science ®Google Scholar
• Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005;72:414-21
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002;186:1142-9
   PubMed Web of Science ®Google Scholar
• Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 2003;67:9-13
   PubMed Web of Science ®Google Scholar
• Dusterberg B, Nishino Y. Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas 1982;4:315-24
   PubMed Web of Science ®Google Scholar
• Ben-Rafaelf Z, Mastroianni L, Meloni F, Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid. J Clin Endocrinol Metab 1986;63:1106-11
   PubMed Web of Science ®Google Scholar
• Lievertz RW. Pharmacology and pharmacokinetics of estrogens. Am J Obstet Gynecol 1987;156:1289-93
   PubMed Web of Science ®Google Scholar
• Lindberg UB, Crona N, Stigendal L, A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost 1989;61:65-9
   PubMed Web of Science ®Google Scholar
• Lee AJ, Cai MX, Thomas PE, Characterization of the oxidative metabolites of 17{beta}-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 2003;144:3382-98
   PubMed Web of Science ®Google Scholar
• Goldzieher JW. Pharmacology of contraceptive steroids: a brief review. Am J Obstet Gynecol 1989;160:1260-4
   PubMed Web of Science ®Google Scholar
• Gommaa AA, Osman FH. Influence of acetaminophen-induced hepatic necrosis on the pharmacokinetics of levonorgestrel. Contraception 1983;28:149-57
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80:436-44
   PubMed Web of Science ®Google Scholar
• Palacios S, Wildt L, Parke S, Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149(1):57-62
   Google Scholar
• Nelson A, Sampson-Landers C, Parke S, Jensen J. Efficacy of estradiol valerate/dienogest OC: results of 3 large studies in North America and Europe [abstract and poster]. Presented at the 57th Annual Clinical Meeting of the American College of Obstetricians & Gynecologists, 2-6 May 2009, Chicago, IL, USA
   Google Scholar
• Qlaira® Summary of Product Characteristics. 22 Dec 2009. Available from: http://emc.medicines.org.uk/medicine/21700/SPC/Qlaira/ [Last accesssed 22 Dec 2009]
   Google Scholar
• Belsey EM. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988;38:181-206
   PubMed Web of Science ®Google Scholar
• Archer DF, Jensen JT, Johnson JV, Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase III study results. Contraception 2006;74:439-45
   PubMed Web of Science ®Google Scholar
• Bachmann G, Sulak PJ, Sampson-Landers C, Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone. Contraception 2004;70:191-8
   PubMed Web of Science ®Google Scholar
• Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception 2007;75:16-22
   PubMed Web of Science ®Google Scholar
• Parke S, Nahum G, Mellinger U, Junge W. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol 2008;111(4 Suppl):12-3
   Web of Science ®Google Scholar
• Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss and iron deficiency. Acta Med Scand 1966;180:639-50
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding. Commissioned by the National Institute for Health and Clinical Excellence. Available from: http://wwwniceorguk/nicemedia/pdf/CG44FullGuidelinepdf [Last accessed 28 October 2009]
   Google Scholar
• Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust NZ J Obstet Gynaecol 1991;31:66-70
   PubMed Web of Science ®Google Scholar
• Fraser IS, Zeun S, Machlitt A, Mellinger U. A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double-blind, randomised, placebo-controlled trial. Int J Gynecol Obstet 2009;107(Suppl 2):S183
   PubMed Web of Science ®Google Scholar
• Jensen J, Machlitt A, Mellinger U, A multicenter, double-blind, randomized, placebo-controlled study of oral estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding. Fertil Steril 2009;92:S32
   Google Scholar
• Goebelsmann U, Mashchak CA, Mishell DR Jr. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. Am J Obstet Gynecol 1985;151:868-77
   PubMed Web of Science ®Google Scholar
• Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception 2006;73:223-8
   PubMed Web of Science ®Google Scholar
• Eilertsen AL, Hoibraaten E, Os I, The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas 2005;52:111-18
   PubMed Web of Science ®Google Scholar
• van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;339:b2921
   PubMed Web of Science ®Google Scholar
• Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890
   PubMed Web of Science ®Google Scholar
• Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-54
   PubMed Web of Science ®Google Scholar
• Seeger JD, Loughlin J, Eng PM, Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110:587-93
   PubMed Web of Science ®Google Scholar